연구성과로 돌아가기

2021 연구성과별 연구자 정보 (1800 / 2991)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer (vol 51, pg 482, 2015) Kang, Yoon-Koo Kang, YK 12 교신저자 Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea ABL-4264-2022 Kang, Yoon-Koo ykkang@amc.seoul.kr;
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Baek, Dong Won, Sr. Baek, DW Sr 1 Kyungpook Natl Univ Hosp, Hematol & Oncol, Daegu, South Korea
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Moon, Joon Ho Moon, JH 2 Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Ahn, Jae-Sook Ahn, JS 3 Chonnam Natl Univ, Hematol Oncol, Hwasun Hosp, Gwangju, Jeollanam Do, South Korea
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Park, Seong Kyu Park, SK 4 Soonchunhyang Univ Hosp, Dept Hematol Oncol, Seoul, South Korea HJA-3755-2022 Park, Jung Hyun
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Song, Ik Chan Song, IC 5 Chungnam Natl Univ Hosp, Dept Internal Med, Daejeon, South Korea
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Lee, Ho-Sup Lee, HS 6 Kosin Univ, Gospel Hosp, Dept Internal Med, Dvis Hematol Oncol,Coll Med, Busan, South Korea
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Lee, Won Sik Lee, WS 7 Inje Univ, Dept Internal Med, Busan Paik Hosp, Busan, South Korea
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Won, Jong Ho Won, JH 8 Soonchunhyang Univ Hosp, Dept Hematol Oncol, Seoul, South Korea AAM-8322-2021 Won, Jongho
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Lee, Hong Ghi Lee, HG 9 Konkuk Univ, Sch Med, Dept Hematol, Med Ctr, Seoul, South Korea F-6974-2013 Lee, Jung-Hye
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Cheong, June-Won Cheong, JW 10 Yonsei Univ, Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Mun, Yeung-Chul Mun, YC 11 Ewha Womans Univ, Dept Hematol, Seoul, South Korea
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Jung, Chul W. Jung, CW 12 Samsung Med Ctr, Seoul, South Korea
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Lee, Je-Hwan Lee, JH 13 Univ Ulsan, Dept Hematol, Coll Med, Seoul, South Korea
Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Lee, Je-Hwan Lee, JH 13 Asan Med Ctr, Seoul, South Korea
페이지 이동: